Olga Petrovic

Dr. Olga Petrovic

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2026 in Cells
Verified
Journal Article
Open access
PDF file
SJStefan Juricic
Stefan Juricic
JKJovana Klac
Jovana Klac
SSSinisa Stojkovic
Sinisa Stojkovic
BBBranko Beleslin
Branko Beleslin
MTMilorad Tesic
Milorad Tesic
DSDejan S Simeunovic
Dejan S Simeunovic
Myocardial ischemia represents a state of reduced coronary perfusion with oxygenated blood, insufficient to meet the metabolic demands of the myocardium. Both acute and chronic ischemia trigger a cascade of cellular events that lead to disturbances in ionic balance, mitochondrial function and energy metabolism. During ischemia, cardiomyocytes (CMs) shift from aerobic to anaerobic metabolism, resulting in adenosine triphosphate (ATP) depletion, loss of ionic homeostasis and calcium (Ca2+) overload that activate proteases, phospholipases and membrane damage. Reperfusion restores oxygen supply and prevents irreversible necrosis but paradoxically initiates additional injury in marginally viable myocardium. The reoxygenation phase induces excessive production of reactive oxygen species (ROS), endothelial dysfunction and a strong inflammatory response mediated by neutrophils, platelets and cytokines. Mitochondrial dysfunction and opening of the mitochondrial permeability transition pore (mPTP) further amplify oxidative stress and inflammation and trigger apoptosis and necroptosis. Understanding these intertwined cellular and molecular mechanisms remains essential for identifying novel therapeutic targets aimed at reducing reperfusion injury and improving myocardial recovery after ischemic events.

25 August 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
APAna Petković
Ana Petković
NMNemanja Menković
Nemanja Menković
OPOlga Petrovic
Olga Petrovic
Ilija BilbijaIlija Bilbija
Ilija Bilbija
NRNikola Radovanovic
Nikola Radovanovic
BIBranislava Ivanovic
Branislava Ivanovic
Background: Infective endocarditis (IE) is a rare disease with a high mortality rate and rising incidence, requiring timely and precise diagnosis in order to choose appropriate therapy. Imaging of morphologic lesions is an integrative part of diagnosis. Artifacts and the patient’s habitus make echocardiography difficult to visualize advanced-form IE. Cardiac computed tomography (CCT) constantly shows an additive diagnostic value due to high resolution of cardiac anatomy. Conjecturally, joint application of both diagnostic tests improves overall sensitivity and specificity in diagnosing IE. Methods: Patients with definite IE underwent transthoracic echocardiography (TTE), transesophageal echocardiography (TEE), and CCT. We analyzed valvular and paravalvular IE lesions in all three imaging methods and compared them to surgical or autopsy findings. We calculated sensitivity, specificity, diagnostic accuracy, and positive and negative predictive value of both imaging tests individually and jointly used. Results: We examined 78 patients, male to female ratio 2:1, mean age 52.29 ± 16.62. We analyzed 85 valves, 70 native valves, 13 prosthetic valves, and 2 corrected valves due to Ozaki procedure, along with a central shunt and 4 pacemaker leads. As a single test, the sensitivity and specificity of CCT, TTE, and TEE for valvular lesions were 91.6/20%, 65.5/57.9%, and 60/84%, and paravalvular lesions were 100/0%, 46/10.5%, and 14.7/100%. When combined together, sensitivity and specificity for valvular lesions rose to 96.6/0% and paravalvular lesions to 100/0%. We also analyzed the diagnostic performance for each test in single and mutual application, per specific IE lesion. Conclusion: In the individual application, CCT in comparison to TTE and TEE shows better diagnostic performance in detection of valvular and paravalvular lesions. In joint application, there is a statistically significant difference in performance compared to their single use, especially in prosthetic valves and invasive forms of IE native valves.

11 October 2022 in Journal of Clinical Ultrasound
Verified
Journal Article
Closed access
DTDanijela Trifunovic-Zamaklar
Danijela Trifunovic-Zamaklar
IJIvana Jovanovic
Ivana Jovanovic
JVJelena Vratonjić
Jelena Vratonjić
OPOlga Petrovic
Olga Petrovic
IPIvana Paunović
Ivana Paunović
BIBranislava Ivanović
Branislava Ivanović

11 October 2022 in Journal of Clinical Ultrasound
Verified
Journal Article
Closed access
BIBranislava Ivanovic
Branislava Ivanovic
JPJovana Popovic
Jovana Popovic
ĐDĐorđe Dukić
Đorđe Dukić
APAna Petkovic
Ana Petkovic
OPOlga Petrovic
Olga Petrovic

17 December 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MOMarina M Ostojic
Marina M Ostojic
MOMladen Ostojic
Mladen Ostojic
OPOlga Petrovic
Olga Petrovic
ONOlga Milos Nedeljkovic-Arsenovic
Olga Milos Nedeljkovic-Arsenovic
FPFrancesco Perone
Francesco Perone
INIvana P Nedeljkovic
Ivana P Nedeljkovic
The confirmed benefits of regular moderate exercise on cardiovascular health have positioned athletes as an illustration of well-being. However, concerns have arisen regarding the potential predisposition to arrhythmias in individuals engaged in prolonged strenuous exercise. Atrial fibrillation (AF), the most common heart arrhythmia, is typically associated with age-related risks but has been documented in otherwise healthy young and middle-aged endurance athletes. The mechanism responsible for AF involves atrial remodeling, fibrosis, inflammation, and alterations in autonomic tone, all of which intersect with the demands of endurance sports, cumulative training hours, and competitive participation. This unique lifestyle requires a tailored therapeutic approach, often favoring radiofrequency ablation as the preferred treatment. As the number of professional and non-professional athletes engaging in high-level daily sports activities rises, awareness of AF within this demographic becomes imperative. This review delivers the etiology, pathophysiology, and therapeutic considerations surrounding AF in endurance sports.

26 June 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
APAna Petković
Ana Petković
NMNemanja Menković
Nemanja Menković
OPOlga Petrovic
Olga Petrovic
Ilija BilbijaIlija Bilbija
Ilija Bilbija
MNMiodrag Nišević
Miodrag Nišević
BIBranislava Ivanovic
Branislava Ivanovic
Infective endocarditis is a rare disease with an increasing incidence and an unaltered high mortality rate, despite medical development. Imaging plays an integrative part in the diagnosis of infective endocarditis, with echocardiography as the initial diagnostic test. Research data in the utility of cardiac computed tomography (CCT) in the diagnostic algorithm of IE are rising, which indicates its importance in detection of IE-related lesion along with the exclusion of coronary artery disease. The latest 2023 European Society of Cardiology Guidelines in the management of IE classified CCT as class of recommendation I and level of evidence B in detection of both valvular and paravalvular lesions in native and prosthetic valve endocarditis. This review article provides a comprehensive and contemporary review of the role of CCT in the diagnosis of IE, the optimization of acquisition protocols, the morphology characteristics of IE-related lesions, the published data of the diagnostic performance of CCT in comparison to echocardiography as the state-of-art method, as well as the limitations and future possibilities.